2017 Fiscal Year Final Research Report
New immunosuppressive therapy using a subset of regulatory T cells
| Project/Area Number |
16K20332
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Juntendo University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Keywords | 角膜移植 / 制御性T細胞 / 誘導性制御性T細胞 / 内在性制御性T細胞 / IL-10 / TGF-β / 角膜移植免疫 / ハイリスク角膜移植 |
|---|
| Outline of Final Research Achievements |
Regulatory T cells (Tregs) are crucial for allograft survival. Tregs can be divided into thymus-derived natural Tregs (tTregs) and peripherally-derived induced Tregs (pTregs). We determine whether the suppressive function of Treg subsets is hampered in hosts who are at high risk for rejecting their graft. We demonstrate that in high-risk recipients the frequencies and function of pTregs (but not tTregs) are suppressed. Reduced function of pTregs correlated with decreased expression of CTLA-4, interleukin-10, and transforming growth factor-β. Adoptive transfer of pTregs from mice at low risk of subsequent graft rejection is able to rescue graft survival in recipients that are at high risk of rejecting their grafts. Our data suggest that impaired function of pTregs, but not tTregs, mediates the loss of immune tolerance and promotes allograft rejection.
|
| Free Research Field |
角膜移植免疫
|
